These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 26922707)

  • 41. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
    Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ
    J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease: a meta-analysis.
    Li X; Kong M; Jiang D; Dong A
    Interact Cardiovasc Thorac Surg; 2014 Mar; 18(3):347-54. PubMed ID: 24345688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CABG Versus PCI: Greater Benefit in Long-Term Outcomes With Multiple Arterial Bypass Grafting.
    Habib RH; Dimitrova KR; Badour SA; Yammine MB; El-Hage-Sleiman AK; Hoffman DM; Geller CM; Schwann TA; Tranbaugh RF
    J Am Coll Cardiol; 2015 Sep; 66(13):1417-27. PubMed ID: 26403338
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Percutaneous intervention versus coronary artery bypass graft surgery in left main coronary artery stenosis: a systematic review and meta-analysis.
    Zhang XL; Zhu QQ; Yang JJ; Chen YH; Li Y; Zhu SH; Xie J; Wang L; Kang LN; Xu B
    BMC Med; 2017 Apr; 15(1):84. PubMed ID: 28427392
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mid-to-long term mortality following surgical versus percutaneous coronary revascularization stratified according to stent subtype: An analysis of 6,682 patients with multivessel disease.
    Raja SG; Ilsley C; De Robertis F; Lane R; Kabir T; Bahrami T; Simon A; Popov A; Dalby MC; Mason M; Grocott-Mason R; Smith RD; Iqbal MB
    PLoS One; 2018; 13(2):e0191554. PubMed ID: 29408926
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Meta-analysis of randomized controlled trials on the treatment of unprotected left main coronary artery disease: one-year outcomes with coronary artery bypass grafting versus percutaneous coronary artery intervention with drug-eluting stent.
    Kajimoto K; Miyauchi K; Yamamoto T; Daida H; Amano A
    J Card Surg; 2012 Mar; 27(2):152-7. PubMed ID: 22364383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Five-year outcomes following PCI with DES versus CABG for unprotected LM coronary lesions: meta-analysis and meta-regression of 2914 patients.
    Sá MP; Ferraz PE; Escobar RR; Nunes EO; Soares AM; Araújo e Sá FB; Vasconcelos FP; Lima RC
    Rev Bras Cir Cardiovasc; 2013 Mar; 28(1):83-92. PubMed ID: 23739937
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Percutaneous coronary intervention versus coronary artery bypass graft for left main coronary artery disease: A meta-analysis.
    Gallo M; Blitzer D; Laforgia PL; Doulamis IP; Perrin N; Bortolussi G; Guariento A; Putzu A
    J Thorac Cardiovasc Surg; 2022 Jan; 163(1):94-105.e15. PubMed ID: 32499076
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials.
    Ahmad Y; Howard JP; Arnold AD; Cook CM; Prasad M; Ali ZA; Parikh MA; Kosmidou I; Francis DP; Moses JW; Leon MB; Kirtane AJ; Stone GW; Karmpaliotis D
    Eur Heart J; 2020 Sep; 41(34):3228-3235. PubMed ID: 32118272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coronary artery bypass grafting versus drug-eluting stents in multivessel coronary disease. A meta-analysis on 24,268 patients.
    Benedetto U; Melina G; Angeloni E; Refice S; Roscitano A; Fiorani B; Di Nucci GD; Sinatra R
    Eur J Cardiothorac Surg; 2009 Oct; 36(4):611-5. PubMed ID: 19394857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coronary Artery Bypass Grafting Versus Drug-Eluting Stents Implantation for Previous Myocardial Infarction.
    Chang M; Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Zeng Y; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    Am J Cardiol; 2016 Jul; 118(1):17-22. PubMed ID: 27181565
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of Outcome of Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation for Non-ST-Elevation Acute Coronary Syndrome.
    Chang M; Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Han M; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    Am J Cardiol; 2017 Aug; 120(3):380-386. PubMed ID: 28595861
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Percutaneous Versus Surgical Revascularization for Left Main or Multivessel Coronary Artery Disease: Results From a Large-Scale Meta-Analysis in the Era of Drug-Eluting Stents.
    Verdoia M; Barbieri L; Kedhi E; Suryapranata H; De Luca G
    Angiology; 2018 Oct; 69(9):812-824. PubMed ID: 29661004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term outcomes of coronary artery bypass grafting versus stent-PCI for unprotected left main disease: a meta-analysis.
    De Rosa S; Polimeni A; Sabatino J; Indolfi C
    BMC Cardiovasc Disord; 2017 Sep; 17(1):240. PubMed ID: 28877676
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
    Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
    Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Second-generation drug-eluting stenting versus coronary artery bypass grafting for treatment of coronary chronic total occlusion.
    Jang WJ; Yang JH; Song YB; Hahn JY; Chun WJ; Oh JH; Kim WS; Lee YT; Yu CW; Lee HJ; Gwon HC; Choi SH
    J Cardiol; 2019 May; 73(5):432-437. PubMed ID: 30611686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myocardial revascularisation in renal dysfunction: a systematic review and meta-analysis.
    Deo SV; Shah IK; Dunlay SM; Erwin PJ; Dillon JM; Park SJ
    Heart Lung Circ; 2013 Oct; 22(10):827-35. PubMed ID: 23548338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Meta-Analysis of Randomized Control Trials Comparing Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Significant Left Main Coronary Narrowing.
    Qian C; Feng H; Cao J; Wei B; Wang Y
    Am J Cardiol; 2017 May; 119(9):1338-1343. PubMed ID: 28267960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.